Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.
Rody A, et al. Among authors: ahr a.
Zentralbl Gynakol. 2006 Apr;128(2):76-81. doi: 10.1055/s-2006-921508.
Zentralbl Gynakol. 2006.
PMID: 16673249
Clinical Trial.
BACKGROUND: Neoadjuvant administration of chemotherapy provides a unique opportunity to monitor response to treatment in breast cancer and assesses response exactly. ...We could observe a switch of receptor expression for ER, PR or HER-2 from positive to negative an …
BACKGROUND: Neoadjuvant administration of chemotherapy provides a unique opportunity to monitor response to treatment in breast cance …